Here are five highlights:
1. In seven years, Medicare spending on the EpiPen increased 1,151 percent.
2. The number of EpiPen users rallied 164 percent from 2007 to 2014.
3. Medicare spent $7 million on EpiPen in 2007 for 79,980 users in 2007.
4. That figure increased to $87.9 million in 2014.
5. In 2014, nearly 211,500 Medicare members used EpiPen.
More articles on coding & billing:
3 legislative changes impacting ASCs — Sept. 21, 2016
Sen. Bernie Sanders and others leading campaign to offer public option on ACA: 5 things to know
Connecticut’s Insurance Commissioner withdrawing from Anthem-Cigna review: 7 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
